HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E L Saenko Selected Research

Factor VIIIa

2/2001Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E L Saenko Research Topics

Disease

12Hemophilia A (Haemophilia)
03/2008 - 02/2001
2Thrombosis (Thrombus)
01/2007 - 02/2005
1Hemorrhage
03/2002
1Prion Diseases (Transmissible Spongiform Encephalopathies)
03/2002

Drug/Important Bio-Agent (IBA)

8Factor VIII (Coagulation Factor VIII)IBA
10/2004 - 02/2001
4AntibodiesIBA
08/2002 - 02/2001
2Proteins (Proteins, Gene)FDA Link
10/2004 - 02/2001
2ThrombinFDA Link
03/2002 - 02/2001
1Blood Coagulation Factors (Coagulation Factor)IBA
03/2008
1Biocompatible Materials (Biomaterials)IBA
01/2007
1Thromboplastin (Tissue Factor)IBA
02/2005
1von Willebrand FactorIBA
08/2002
1Phospholipids (Phosphatides)FDA LinkGeneric
08/2002
1Complementary DNA (cDNA)IBA
06/2001
1AutoantibodiesIBA
03/2001
1Protein CIBA
02/2001
1Factor VIIIaIBA
02/2001
1Antigen-Antibody Complex (Immune Complex)IBA
02/2001

Therapy/Procedure

2Therapeutics
07/2006 - 08/2001